Support DNDi through philanthropy
Your philanthropic giving helps us transform lives
While some diseases and viruses receive a great deal of attention, others are almost completely ignored. This is the daily reality for the 1.7 billion people worldwide who are affected by neglected diseases or diseases of poverty.
In this reality, there are diseases for which there are no existing treatments. In this reality, there are diseases for which the treatments that do exist are painful, unsafe, or completely unsuitable for children. In this reality, those living in the poorest and least stable settings are most likely to be affected, with women, children, and others facing stigmatization or intolerance particularly vulnerable.
Here’s where the Drugs for Neglected Diseases initiative comes in. At DNDi, we put neglected patients at the heart of medical R&D.
An innovative solution
Complex problems need ingenious solutions, and DNDi by its very nature is an innovative solution. Our unique partnerships-based model gives us flexibility and freedom to develop treatments for diseases at a greatly reduced cost.
Where the cost of a new drug produced by the pharmaceutical industry has been estimated at over USD 1 billion, DNDi’s costs are much lower, in part due to pro bono contributions from our industrial and academic partners.
Our open innovation model aims to produce drugs that are affordable, available, and adapted to the communities who need them.
Why support DNDi’s work?
Whether you are passionate about supporting a particular issue or geography, or choose to become a member of the Innovators, a group of visionary philanthropists, your support will truly create lasting change for those who need it most.
- We deliver. To date we have created 9 new treatments for 6 deadly diseases. Our malaria treatments have been used by more than 500 million patients; and we recently introduced a ground-breaking novel drug for sleeping sickness, a deadly disease spread by the tsetse fly in central Africa, an innovation which means it should be possible to eliminate sleeping sickness altogether.
- Our work is grounded in the best science – and it’s open access. Our treatments have been approved and recommended by the U.S. Food and Drug Administration, European Medicines Agency, and World Health Organization, and our scientists publish regularly in top journals. See some of our recent articles.
- We work hand in hand with our founding partners: Médecins Sans Frontières, the World Health Organization, Institut Pasteur, Indian Council of Medical Research, the Oswaldo Cruz Foundation in Brazil, the Kenyan Medical Research Institute, and the Malaysian Ministry of Health.
- Excellent global health outcomes. Interventions on neglected tropical diseases yield an estimated net benefit of about USD 25 per USD 1 invested, making them “one of the ‘best buys’ in global public health” according to the World Health Organization.
- We advocate for voices that are not well heard. We work with national health ministries, global and regional bodies, civil society, and other groups to build the case for accessible treatments for neglected population groups.
- We support innovation and build expertise in low- and middle-income countries through our work with researchers and our clinical trials run in low-resource settings.
How will DNDi work with me?
Whether you are interested in supporting us as an individual philanthropist, as a family or through a trust, foundation, or company, you can get in touch with our dedicated philanthropy team by emailing firstname.lastname@example.org.
You can also donate online today.